Table 2.

Novel COVID-19 Treatments.^a

Variable	Barotrauma (n = 75)	Control (n = 206)	P-value
Hydroxychloroquine	69 (92.00%)	183 (88.83%)	0.441
Azithromycin	68 (90.67%)	182 (88.35%)	0.5834
Ceftraxione	62 (82.67%)	170 (82.52%)	0.978
Remdesivir	16 (21.33%)	33 (16.02%)	0.299
Steroids	51 (68.00%)	114 (55.34%)	0.057
Anti-IL-6 therapy	24 (32.00%)	40 (19.42%)	0.026
Convalescent Plasma	4 (5.33%)	18 (8.74%)	0.347

^a Bold text denotes statistically significant values.